On Oct. 25, a nurse at the ASC found a discrepancy in the number of fentanyl vials used by Dr. Christensen that day and reported the information to the Wyoming Professional Assistance Program.
Dr. Christensen later admitted he diverted a vial but did not use it, as well as that he had used fentanyl earlier in the year. He then failed to provide a nail sample for testing, the report said.
The Wyoming Board of Medicine suspended his license Dec. 5.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
